Moreover, as PIK3CA mutational status in breast cancer was reported to change dramatically between primary tumors and corresponding metastatic [12, 13], sequential biopsy is essential to monitor treatment response and disease progression. The gene discussed is PIK3CA; the disease is breast carcinoma.